Literature DB >> 18040288

The transmembrane domain of TACE regulates protein ectodomain shedding.

Xiaojin Li1, Liliana Pérez, Zui Pan, Huizhou Fan.   

Abstract

Numerous membrane proteins are cleaved by tumor necrosis factor-alpha converting enzyme (TACE), which causes the release of their ectodomains. An ADAM (a disintegrin and metalloprotease domain) family member, TACE contains several noncatalytic domains whose roles in ectodomain shedding have yet to be fully resolved. Here, we have explored the function of the transmembrane domain (TM) of TACE by coupling molecular engineering and functional analysis. A TM-free TACE construct that is anchored to the plasma membrane by a glycosylphosphatidylinositol (GPI)-binding polypeptide failed to restore shedding of transforming growth factor-alpha (TGF-alpha), tumor necrosis factor-alpha (TNF-alpha) and L-selectin in cells lacking endogenous TACE activity. Substitution of the TACE TM with that of the prolactin receptor or platelet-derived growth factor receptor (PDGFR) also resulted in severe loss of TGF-alpha shedding, but had no effects on the cleavage of TNF-alpha and L-selectin. Replacement of the TM in TGF-alpha with that of L-selectin enabled TGF-alpha shedding by the TACE mutants carrying the TM of prolactin receptor and PDGFR. Taken together, our observations suggest that anchorage of TACE to the lipid bilayer through a TM is required for efficient cleavage of a broad spectrum of substrates, and that the amino-acid sequence of TACE TM may play a role in regulatory specificity among TACE substrates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040288     DOI: 10.1038/cr.2007.98

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  9 in total

1.  The transmembrane domains of L-selectin and CD44 regulate receptor cell surface positioning and leukocyte adhesion under flow.

Authors:  Konrad Buscher; Sebastian B Riese; Mehdi Shakibaei; Christian Reich; Jens Dernedde; Rudolf Tauber; Klaus Ley
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

2.  Interaction of calmodulin with L-selectin at the membrane interface: implication on the regulation of L-selectin shedding.

Authors:  Wei Deng; Sankaranarayanan Srinivasan; Xiaofeng Zheng; John A Putkey; Renhao Li
Journal:  J Mol Biol       Date:  2011-06-02       Impact factor: 5.469

3.  Inhibitory role of TACE/ADAM17 cytotail in protein ectodomain shedding.

Authors:  Xiaojin Li; Liliana Pérez; Huizhou Fan
Journal:  World J Biol Chem       Date:  2011-11-26

4.  ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site.

Authors:  Sylvain M Le Gall; Thorsten Maretzky; Priya D A Issuree; Xiao-Da Niu; Karina Reiss; Paul Saftig; Rama Khokha; Daniel Lundell; Carl P Blobel
Journal:  J Cell Sci       Date:  2010-10-27       Impact factor: 5.285

5.  Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.

Authors:  Erica M Hanson; Virginia K Clements; Pratima Sinha; Dan Ilkovitch; Suzanne Ostrand-Rosenberg
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

6.  Exploration of chlamydial type III secretion system reconstitution in Escherichia coli.

Authors:  Xiaofeng Bao; Wandy L Beatty; Huizhou Fan
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

7.  Plasma membrane microdomains regulate TACE-dependent TNFR1 shedding in human endothelial cells.

Authors:  Alessio D'Alessio; Bianca Esposito; Claudia Giampietri; Elio Ziparo; Jordan S Pober; Antonio Filippini
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

8.  Increased activity of cell surface peptidases in HeLa cells undergoing UV-induced apoptosis is not mediated by caspase 3.

Authors:  Terrence J Piva; Catherine M Davern; Paula M Hall; Clay M Winterford; Kay A O Ellem
Journal:  Int J Mol Sci       Date:  2012-02-28       Impact factor: 6.208

9.  Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation.

Authors:  Qi Wang; Jia Wei; Xi Jia; Xiao Feng; Zhenghua Ji; Xueqiang Ji; Xuejun Shao
Journal:  BMC Pediatr       Date:  2022-03-30       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.